Patent directory · USPTO A61K / A61P
Patents matching “CTOR”
756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12275964
Variant type V CRISPR/Cas effector polypeptides and methods of use thereof
granted -
US 12269803
Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease
granted -
US 12257288
Methods of inducing immune tolerance to clotting factors
granted -
US 12247226
Cellular reprogramming using temporal and transient plasmid vector expression system
granted -
US 12246057
Transmembrane stem cell factor (tm-SCF) lipid nanocarriers and methods of use thereof
granted -
US 12240918
Bispecific antibodies against plasma kallikrein and factor XII
granted -
US 12239692
Adeno-associated virus factor VIII vectors
granted -
US 12240914
Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof
granted -
US 2025064917
HVT AIV VECTORS AND USES THEREOF
granted -
US 12226437
Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell
granted -
US 12214023
Compositions and methods for expressing factor IX
granted -
US 12213996
Methods of treating optic nerve diseases using neural progenitor cell growth factors
granted -
US 12213998
Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
granted -
US 12214031
Mannheimia haemolytica vector
granted -
US 12201721
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
granted -
US 12186375
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
granted -
US 12188039
Recombinant adeno-associated viral vector for gene delivery
granted -
US 12173317
Use of histone modifiers to reprogram effector T cells
granted -
US 12171741
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12173274
Enhanced immune effector cells and use thereof
granted -
US 12173307
Methods for the purification of viral vectors
granted -
US 12161724
Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens
granted -
US 12161696
Methods of treating hemophilic arthropathy using chimeric clotting factors
granted -
US 12156877
Methods of treating conditions related to a thiamine deficiency, a thiamine-dependent enzyme, or an associated cofactor
granted